During the past decade, Wagner and Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wagner and Associates" are "Malignant Melanoma" (2 trials). Many other conditions were trialed in "Wagner and Associates" in a lesser frequency.

Most popular intervention types in "Wagner and Associates" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "CancerVax vaccine (CANVAXIN)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wagner and Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Wagner and Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Wagner and Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wagner and Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".